Dendritic cells are a small subset of human blood mononuclear cells that are potent stimulators of several T cell functions. Here we show they are 10-50-fold more potent than monocytes or B cells in inducing T cell responses to a pand of superantigens. Furthermore, dendritic calls can present femtomolar concentrations of superantigen to T calls even at numbers where other antigen-presenting calls (APCs) are inactive. Although dendritic cells express very high levels of the major histocompatibility complex products that are required to present superantigens, it is only necessary to pulse these APCs for 1 hour with picomolar levels of one superantigen, staphylococcal enterotoxin 13, to maximally activate T cells. Our results suggest that very small amounts of superantigen will be immunogenic in vivo if presented on dendritic calls.
Staphylococcus aureus induce gastroenteritis, toxic shock syndrome, and the scalded skin syndrome (1, 2) . In rodents, the only species of Mycoplasma known to produce a superantigen, M~,coplasma arthritidis, causes a chronic inflammatory polyarthritis (3, 4) .
Superantigens share several important features that distinguish them from conventional antigens. Superantigens are potent mitogens for both human and mouse T cells because they typically stimulate large numbers of T cells bearing particular TCR V~ gene products (5, 6) . T cell responses to superantigens are not MHC restricted in the classical sense since the superantigen is bound and presented by a variety of allelic and isotypic MHC molecules (7) . Superantigens appear to bind to sites on MHC class II molecules that are located outside the peptide binding groove (8, 9) . Where it has been studied, binding to MHC class II antigens is halfmaximal at nanomolar to micromolar levels of superantigen (10) (11) (12) .
Despite the considerable information available regarding binding of superantigens to MHC molecules, there is little known comparing the presenting function of different types of MHC class II + cells, particularly dendritic cells. We have compared the capacity of blood dendritic cells with B cells and monocytes to present staphylococcal toxins and M. at-
thritidis mitogen (MAM) t to human T cells. We find that dendritic cells are 10-50-fold more e~cient than other APCs and require only trace levels of superantigen to initiate T cell responses.
Materials and Methods
Culture Medium. RPMI 1640 (Gibco Laboratories, Grand Island, NY) supplemented with 5% human serum, and 50 #g/ml gentamycin was used.
Mitogens. Staphylococcal enterotoxins (SEs) A, 13 , and E, and toxic shock syndrome toxin 1 (TSST-1) were purchased from Toxin Technology (Madison, WI). The mitogens were aliquoted to 10 ~tg/ml in ILPMI and stored at -20 ~ until use. The mitogen MAM, a culture supernatant of M. ankritidis, was used at a dilution of 1:4,000.
Preparation of Lymphoid Cells. Lymphoid cells were isolated from buffy coats obtained from the New York Blood Center and separated into T cell-enriched (erytMocyte rosette-positive [ER*]) and T cell-depleted (ER-) fractions by rosetting with neuraminidasetreated SRBC.
T Cells. The ER § cells were then depleted of non-T cells by panning on human Ig-coated plastic dishes (13) and by panning Ia § cells with the mAb 9.3C9 (no. HB180; American Type Culture Collection, RockviUe, MD). The resulting T cell preparations failed to proliferate to optimal doses of superantigens indicating negligible contamination with APCs.
Monoo/tes. The ER-fraction was adhered to plastic dishes for 60-90 rain and nonadherent cells were removed with four to five washes. Firmly adherent monocytes were collected by incubating the dishes with cold PBS for 15-20 rain and gentle aspiration. Alternatively, the adherent cells were cultured with fresh medium overnight, at which time the cells were easily dislodged from the plastic surfaces.
B Cells and Dendritic Cells. Nonadherent ER-cells were depleted of residual monocytes by panning on Ig-coated plates and then layered onto 14.5% metrizamide (13) . After sedimentation at 650 g for 10 min at room temperature, B cells and a few NK ceils "pellet" as the high density fraction, while dendritic cells float as the low density fraction (13) . The cell fractions were washed in successively less hypertonic washes before being tested.
Cell Sorting. In some experiments, the APC populations were purified further by cell sorting on a FACStar Plus | (Becton Dickinson & Co., Mountain View, CA), 10' cells were stained with a cocktail of PE-conjugated mAb (10 #1 of stock-purchased mAb in 1 ml of medium) on ice for 45 rain, washed three times, and sorted (13) . B cells were collected as small Leu-4-, Leu-11-, Leu-19-, Leu-M3-negative cells; dendritic cells were large Leu-4-, Leu-11-, Leu-12-, Leu-16-, Leu-19-, Leu-M3-negative cells; and monocytes were large Leu-4-, Leu-11-, Leu-12-, Leu-16-, Leu-19-negative cells. At doses of 5-10 ng/ml, maximal T cell proliferation to the staphylococcal toxins was observed at days 2-3 of culture. The T cell proliferative response to M.AM was considerably slower, reaching maximal levels at days 4-5. For this superantigen, monocytes and B cells were strikingly less e~cient than dendritic cells ( Fig. 1 B) .
Results

Dendritic
In the presence of superantigens, dendritic cells appeared to engage T cells in clusters or aggregates as described previously for other T cell responses; e.g., the MLR (14) . The superiority of dendritic cells to other APCs could not be accounted for by time course differences since pulsing cultures at later intervals showed similar differences between these cells (data not shown). In the allogeneic MLR, dendritic cells are the most potent APC when compared with other cells (14) . A corresponding allogeneic MLR ( Fig. 1 A) Figure 2 . Purified dendritic cells are the most potent APCs for superantigens. APCs were purified by sorting on a FACStar ~ as described (Materials and Methods) and added at graded doses to T cells with a pand of superantigens.
were not responsible for the efficient superantigen presentation. When compared with sorted B cells and monocyte preparations, dendritic cells were consistently 10-50-fold more potent in presenting TSST-1 (10 ng/ml) and SEB (5 ng/ml; These experiments also consistently showed that B cells were less potent than monocytes in presenting superantigens. With TSST-1, especially, B cells were poorly stimulatory.
Femtomolar Concentrations of Staphylococcal Enterotoxins Can Be E~ciently Presented by Dendritic Cells.
The ability of different APCs to stimulate T cells in the presence of a wide range of enterotoxin concentrations was evaluated (Table 1) . At picomolar to femtomolar concentrations of SEE, dendritic cells induced T cell proliferation even when present in limiting numbers (1:300). In fact, the data suggest that dendritic cells would be effective at doses of SEE <5 pg/ml (170 fM). Monocytes and B cells stimulated T cells at femtomolar concentrations of SEE, but were less eflficient, and relatively high stimulator to responder ratios (1:10-30) were required.
Expression of MHC Class II Antigens by Human Blood
APCs. Superantigens bind to MHC class II molecules on APCs (11, 12, 15, 16) . It was therefore of interest to compare fold more DR, DP, or DQ molecules, as detected by intensity of staining (Fig. 3, bottom three panels) . Superantigen Binding Activity of Dendritic Cells. The above results suggest that dendritic cells are more efficient at presenting superantigens because of their higher expression of Ia antigens. To gain a sense of the degree of occupancy of class II, we did pulsing experiments with graded doses of SEB. Dendritic cells and B cells were pulsed with femtomolar to nanomolar concentrations of SEB for 1 h at 37~ washed extensively, and added in graded doses to purified T cells. An additional group of APCs (nonpulsed) were directly added in the continuous presence of T cells and SEB. At stimulator/responder ratios of 1:100, maximal T cell stimulation was achieved at 10-100 ng/ml for nonpulsed and pulsed cells ( Table 2 ). Half-maximal stimulation was seen when dendritic cells were pulsed at 1 ng/ml (pM) of SEB. Dendritic cells pulsed with even femtomolar (10 pg/ml) concentrations of superantigen stimulated T cells to proliferate. Published data show that the Kd for SEB is 10 -6 (11). Therefore, our results suggest that only small amounts of superantigen are needed on dendritic cells to maximally stimulate T cells. In contrast to dendritic cells, SEB-pulsed B cells failed to stimulate T cells even at stimulator/responder ratios of 1:30 (data not shown).
Discussion
Antigen presentation by MHC products on dendritic cells has been studied in the allogeneic MLR (14) , and in responses to nominal antigen (17) or self-MHC (18) . In all of these systems, dendritic cells are effective at very low numbers, e.g., at stimulator/responder ratios of 1:100. Other APCs are considerably less effective or are required at considerably higher numbers. Here we show that dendritic cells are also potent APCs for several superantigens. They are 10-50-fold more effective than monocytes or B cells, and very low numbers of dendritic cells (stimulator/responder ratios of 1:3,000) are effective. At these trace numbers, dendritic cells are not stimulatory in the allogeneic MLR. Our data confirm that femtomolar concentrations of superantigen are sufficient to stimulate T cells (15, 19) . In general, previous studies evaluating superantigen presentation by APCs have used B cell lines, B cells, monocytes, or Ia-transfected fibroblasts (5, 16, (19) (20) (21) (22) . In most cases, however, it has been necessary to use these APCs at high stimulator/responder ratios (generally from 1:100 to 1:2.5) to elicit responses from T cells.
Dendritic cells were consistently better than monocytes or B cells in presenting staphylococcal toxins and MAM. With MAM, however, we noted even greater differences in the efficiency of presentation relative to monocytes and B cells (Fig. 2 B) . It is possible that MAM is presented differently by dendritic cells than other superantigens. Alternatively, MAM may bind with variable efficiency to different class II MHC isotypes (e.g., DQ or DP) that are preferentially expressed on dendritic cells (Fig. 3) .
The efficiency with which dendritic cells present superantigen to T cells is consistent with the degree of Ia antigen Dendritic cells were pulsed with varying doses of SEB, 1/~g/ml (35 nM) to 10 pg/ml (350 fM), for 1 h at 37~ washed, and then added in graded doses to T cells. Nonpulsed dendritic cells were added directly to T cells after which SEB was aliquoted in the same concentrations as above. expression that is expressed on their surface. Dendritic cells express from 10-to 100-fold more DR, DQ, DP on their surfaces than B cells or monocytes. Thus, dendritic cells would have a major advantage in binding or presenting superantigens to T cells since they: (a) would quantitatively bind more superantigen, and (b) express all three class II isotypes at high densities.
However, it appears that only a few of the Ia molecules on dendritic cells are utilized for presentation of superantigen. Dendritic cells pulsed for only 1 h with 10-100 ng/ml of SEB are as efficient as those exposed to the same concentrations of SEB continuously in culture for 3 d (Table 2) . We find that pulsing dendritic cells with these picomolar concentrations of SEB leads to rapid and extensive clustering with T cells. Half-maximal proliferation of T cells is achieved after a pulsing dose of 1 ng/ml or 35 pM, whereas the published Kd for SEB, as determined on B cell lines, is 1/zM (11) . In fact, pulsing dendritic cells with 10 pg/ml (350 fM) still results in T cell activation (Table 2) . Furthermore, since dendritic cells pulsed with picomolar concentrations of SEB can activate T cells when present at 1 cell per 1,000 T cells, only trace numbers are necessary. While other investigators have shown that superantigen-pulsed APCs stimulate T cells (23) (24) (25) , in general, considerably higher doses have been used
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(1 #g/ml). In one other study, Ia + B cell lines were shown to present SEA to T cells after a 1-h pulse with 1 ng/ml, but graded doses of superantigen or APCs were not tested (15) . Our data suggest that for dendritic cells, a very small fraction of MHC class II molecules need to be occupied to stimulate a T cell. In some respects, superantigen presentation resembles peptide presentation where small amounts of antigen suffice and can saturate the system. Thus, superantigen stimulation of T cells may be a useful and simple model to study the accessory functions that allow dendritic cells to stimulate so well. We have begun to assess the contribution of other molecules that are known to be involved in APC-T cell interactions. Blood dendritic cells express high levels of two 13-2 integrins (LFA-1/CDlla and CD11c) and the adhesins leukocyte function-associated antigen 3 (LFA-3) and intercellular adhesion molecule 1 (ICAM-1) (13). Interaction of superantigens with Ia antigens on B cell lines leads to activation of LFA-1 molecules and more efficient homotypic aggregation of the calls (26) . ICAM-1 has recently been shown to provide co-stimulator function for SEA-specific MHC class II--dependent activation of resting CD4 + T cells (27) . Furthermore, dendritic ceils express B7/BB1, the receptor for CD28, and these antigens are important participants in T cell activation and the generation of the allogeneic MLR by dendritic cells (Young, J. W., K. Koulova, S. A. Soergel, E. A. Clark, R. M. Steinman, and B. Dupont, manuscript submitted for publication). Thus, it is possible that the abundant expression of Ia antigens on dendritic cells is not the only feature that permits them to bind and present superantigens at low concentrations or trace numbers in vitro, Consistent with this interpretation, we and others (5, 19) have shown that B cells, which express a higher degree of Ia antigens on their surfaces than do monocytes (Fig. 3) , appear to be less efficient than monocytes in superantigen presentation. Furthermore, when B cells are pulsed with as much as 1 #g/ml of SEB, they are nonstimulatory even at stimulator/responder ratios of 1:30 (data not shown). Superantigens have profound effects when given in vivo. Neonatal mice given SEB delete Vfl3 + and Vfl8 + T cells (28) . Injection of SEB into mice results in expansion followed by clonal anergy and a partial deletion of Vfl8.1 + CD4 + T cells (29) . Patients suffering from toxic shock syndrome have elevated levels of Vfl2 + T cells (30) . Massive stimulation of these T cells in vivo leads to the release of mediators such as TNF and IL-2, which may be responsible for inducing shock-like syndromes after infection (31) . Likewise, APCs are stimulated to secrete IL-1 and TNF after stimulation with superantigens, and this compounds the clinical disease (32, 33) . Because of the need for low levels of superantigen, our findings raise the possibility that dendritic cells are important APCs during inaction by organisms that generate superantigens. Dendritic cells can stimulate T cells in a V/g-selective manner (data not shown), and they and their counterparts have been identified in blood, gut, skin, heart, and joint effusions (34) (35) (36) (37) (38) . These are all organ systems involved in diseases that are likely to be caused by microbial superantigens. Furthermore, dendritic cells are known to migrate from tissues to lymph and blood, and then lymph nodes and spleen where presentation to T cells would occur (39) . For limiting or subsaturating concentrations of superantigen, dendritic cells are likely to be the first avenue whereby these proteins are encountered in the body. In recent studies in mice, dendritic cells have been shown to present the endogenous superantigens (Mls) in vivo (40) . Given these findings, it is possible that very low levels of superantigens can stimulate T cells and cause inflammation and tissue damage in situ.
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